Merck & Co

Merck pays $30 million upfront to acquire cancer therapy developer Modifi Biosciences

24 Oct 2024

US pharma multinational Merck has acquired Modifi Biosciences, a developer of new oncology drug molecules, for $30 million upfront and up to $1.3 billion

Merck and Daiichi partner on a $5.5 billion deal for cancer therapy development

20 Oct 2023

The American pharmaceutical company Merck will start a joint venture with Daiichi Sankyo to develop three of its candidate cancer drugs.

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

AstraZeneca and Merck in $8.5-billion oncology deal

27 Jul 2017

Merck calls off late-stage trial of Alzheimer’s drug verubecestat

15 Feb 2017

Merck wins $2.54 bn in royalties in patent lawsuit

16 Dec 2016

Merck & Co among five pharmaceutical companies in the race for Medivation

18 Aug 2016

Merck & Co and Allergan eye US biotechnology company Biogen

03 Aug 2016

Merck gets a $5-mn Ebola vaccine shot from Vaccine Alliance

22 Jan 2016

EU conditional nod for Merck's $17-bn purchase of Sigma-Aldrich

16 Jun 2015

Sigma-Aldrich is a life science and technology company that manufactures and distributes more than 230,000 chemicals, biochemicals and other essential products globally to research and applied labs as well as in industrial and commercial markets